| Tag | Content |
|---|
EnhancerAtlas ID | HS058-02854 |
Organism | Homo sapiens |
Tissue/cell | GM10847 |
Coordinate | chr16:11670790-11671380 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NEUROG1 | MA0623.2 | chr16:11670915-11670925 | GACATATGTC | + | 6.02 | | NEUROG1 | MA0623.2 | chr16:11670915-11670925 | GACATATGTC | - | 6.02 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_10082 | chr16:11670345-11671514 | CD14 | | SE_20221 | chr16:11670210-11671339 | CD56 | | SE_22505 | chr16:11670258-11671321 | CD8_primiary | | SE_61608 | chr16:11668804-11735966 | Toledo | | SE_62803 | chr16:11650953-11682137 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I011574 | chr16 | 11668452 | 11671606 |
|
Enhancer Sequence | CAATCTTGCC TTTAGCAAGA CTTACGGATA ATGTGGGAAC AGGGTGGTGG TGGACATTGC 60
CTGTCAAGCG CTTTTCATGC CTGTTTCACA TCCCCTGGCT GACACCACAT GATCTAGCCC 120
TTGATGACAT ATGTCTTCCT CCTGCATCCT AATTGCTTCC TGTCTGCAAG TTAGCTTCTA 180
TTAATATTTC CCTAACTGGA CCATATTACG TTACTCTCTG CCCACCCCAG GGGAAGGGAT 240
GTGATCTATA TTTCCCCACG AGGGCTTGAG AAAGCCAAGT GCATCTGACA TCCTTGCACA 300
GCTGAGGTCT CCTGTGCCCA TATGGCACAT CTATCCCATC TATGACAGGG TATCTATGGC 360
ATCAGCTCAT TAGAAGTGTC TATTTTTTTT TTTTTTTTTT TGAGACGGAG TCTCCCTCTG 420
TTGCCCAGGC TGGAGTGCAG TGGCACAATC TCGGCTCACT GCAAGCTCCA CCTTCCAGGT 480
TCAAGCAATT GTCCTGCCTC AGCCTCCCGA GTAGCCGAGA TTACAGGCAC CCACCACCAC 540
GCCCGGCTAG TTTTTGTACT TTTAGTAGAG ATGAGGTTTC ACCATGCTGG 590
|
